Sequana Medical NV
Sequana Medical NV develops and commercializes treatments for patients with diuretic-resistant fluid overload in liver disease, cancer, and heart failure in Belgium, Germany, France, and internationally. The company offers alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; and Direct Sodium Removal (DSR) for the treatment of fluid over… Read more
Sequana Medical NV (SEQUA) - Total Liabilities
Latest total liabilities as of June 2025: €53.74 Million EUR
Based on the latest financial reports, Sequana Medical NV (SEQUA) has total liabilities worth €53.74 Million EUR as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Sequana Medical NV - Total Liabilities Trend (2014–2024)
This chart illustrates how Sequana Medical NV's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Sequana Medical NV Competitors by Total Liabilities
The table below lists competitors of Sequana Medical NV ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Archtis Ltd
AU:AR9
|
Australia | AU$15.84 Million |
|
Strategic Investments A/S
CO:STRINV
|
Denmark | Dkr89.37 Million |
|
Aspermont Ltd
AU:ASP
|
Australia | AU$12.17 Million |
|
Mauch Chunk Trust Financial Corp
PINK:MCHT
|
USA | $656.12 Million |
|
Singulus Technologies AG
XETRA:SNG
|
Germany | €109.60 Million |
|
Sejoong Co. Ltd
KQ:039310
|
Korea | ₩15.13 Billion |
|
Lake Victoria Gold Ltd
OTCQB:LVGLF
|
USA | $4.42 Million |
Liability Composition Analysis (2014–2024)
This chart breaks down Sequana Medical NV's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.20 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.37 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 3.69 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Sequana Medical NV's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Sequana Medical NV (2014–2024)
The table below shows the annual total liabilities of Sequana Medical NV from 2014 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €54.32 Million | +83.73% |
| 2023-12-31 | €29.57 Million | +4.92% |
| 2022-12-31 | €28.18 Million | +81.89% |
| 2021-12-31 | €15.49 Million | +9.87% |
| 2020-12-31 | €14.10 Million | +67.38% |
| 2019-12-31 | €8.42 Million | -61.88% |
| 2018-12-31 | €22.10 Million | +171.85% |
| 2017-12-31 | €8.13 Million | -22.39% |
| 2016-12-31 | €10.48 Million | +110.92% |
| 2015-12-31 | €4.97 Million | +55.52% |
| 2014-12-31 | €3.19 Million | -- |